208 related articles for article (PubMed ID: 27699470)
1. Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children - results of a prospective study.
Wohlgemuth WA; Müller-Wille R; Teusch V; Hammer S; Wildgruber M; Uller W
Eur Radiol; 2017 Jun; 27(6):2482-2488. PubMed ID: 27699470
[TBL] [Abstract][Full Text] [Related]
2. Ethanol-Gel Sclerotherapy of Venous Malformations: Effectiveness and Safety.
Teusch VI; Wohlgemuth WA; Hammer S; Piehler AP; Müller-Wille R; Goessmann H; Uller W
AJR Am J Roentgenol; 2017 Dec; 209(6):1390-1395. PubMed ID: 28929808
[TBL] [Abstract][Full Text] [Related]
3. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin.
Songsaeng D; Churojana A; Khumthong R; Mahiwan L
J Med Assoc Thai; 2015 Apr; 98(4):408-13. PubMed ID: 25958717
[TBL] [Abstract][Full Text] [Related]
4. Ethanol sclerotherapy for venous malformation.
Steiner F; FitzJohn T; Tan ST
ANZ J Surg; 2016 Oct; 86(10):790-795. PubMed ID: 25182969
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound with perfusion analysis in patients with venous malformations before and after percutaneous treatment with ethanol-gel.
Huf VI; Wohlgemuth WA; Uller W; Piehler AP; Goessmann H; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2020; 76(2):161-170. PubMed ID: 32925019
[TBL] [Abstract][Full Text] [Related]
6. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.
Park HS; Do YS; Park KB; Kim KH; Woo SY; Jung SH; Kim DI; Kim YW; Hyun D; Cho SK; Choo IW
Eur Radiol; 2016 May; 26(5):1301-10. PubMed ID: 26307182
[TBL] [Abstract][Full Text] [Related]
8. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
9. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
[TBL] [Abstract][Full Text] [Related]
10. Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol.
Weitz-Tuoretmaa A; Keski-Nisula L; Rautio R; Laranne J
Acta Radiol; 2018 Aug; 59(8):946-952. PubMed ID: 29124942
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness Analysis of Percutaneous Sclerotherapy for Venous Malformations.
Ono Y; Osuga K; Takura T; Nakamura M; Shibamoto K; Yamamoto A; Fujiwara H; Mimura H; Tomiyama N
J Vasc Interv Radiol; 2016 Jun; 27(6):831-7. PubMed ID: 26972615
[TBL] [Abstract][Full Text] [Related]
12. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy of Diffuse and Infiltrative Venous Malformations of the Hand and Distal Forearm.
Guevara CJ; Gonzalez-Araiza G; Kim SK; Sheybani E; Darcy MD
Cardiovasc Intervent Radiol; 2016 May; 39(5):705-710. PubMed ID: 26678548
[TBL] [Abstract][Full Text] [Related]
14. Venous Malformations Sclerotherapy: Outcomes, Patient Satisfaction and Predictors of Treatment Success.
Khaitovich B; Kalderon E; Komisar O; Eifer M; Raskin D; Rimon U
Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1695-1701. PubMed ID: 31538233
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous sclerotherapy for spongiform venous malformations - analysis of patient-evaluated outcome and satisfaction.
Clemens RK; Baumann F; Husmann M; Meier TO; Thalhammer C; MacCallum G; Amann-Vesti BR; Alomari AI
Vasa; 2017 Oct; 46(6):477-483. PubMed ID: 28841126
[TBL] [Abstract][Full Text] [Related]
16. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
17. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
Andreisek G; Nanz D; Weishaupt D; Pfammatter T
J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
[TBL] [Abstract][Full Text] [Related]
18. Peripheral venous malformations with a dominant outflow vein: results of ethanol embolization.
Rokni-Yazdi H; Ghajarzadeh M; Keyvan AH; Namavar MJ; Azizi S
Acta Med Iran; 2014; 52(11):868-71. PubMed ID: 25415823
[TBL] [Abstract][Full Text] [Related]
19. Combined Nd:YAG laser and bleomycin sclerotherapy under the same anesthesia for cervicofacial venous malformations: A safe and effective treatment option.
Gregory S; Burrows PE; Ellinas H; Stadler M; Chun RH
Int J Pediatr Otorhinolaryngol; 2018 May; 108():30-34. PubMed ID: 29605361
[TBL] [Abstract][Full Text] [Related]
20. Sclerotherapy Improves Symptoms in Patients with Small and Moderate Diameter Low-Flow Vascular Malformations: A Prospective Cohort Study.
Leal BAN; Procópio RJ; Dardik A; Navarro TP
Ann Vasc Surg; 2023 Feb; 89():68-77. PubMed ID: 37466046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
